Industry News

Cogentix Medical, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the urology market, today announced that it has entered into a securities purchase agreement with Accelmed Growth Partners, L.P. Under the terms of the securities purchase agreement, Accelmed would purchase $25 million of Cogentix Medical common stock from the Company at $1.55 per share, a 29% premium over the..."/>
Cogentix Medical Enters Into Definitive Agreement For $25 Million Equity Investment
DelMar Pharmaceuticals, Inc., a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, and Accurexa Inc., a company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today a collaboration to develop a novel formulation for the local delivery of combination chemotherapy for the treatment..."/>
DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer
NeuroVive Pharmaceutical AB, the mitochondrial medicine company, today announces that the company is scheduled to present at the Rodman& Renshaw 18th Annual Global Investment Conference held September 11-13, 2016 in New York, US. During the presentation, an update regarding NeuroVive's research and development programs will be provided. The presentation will include the clinical phase II projects related to acute kidney injury prevention and treatment of traumatic..."/>
Neurovive Pharmaceutical: NeuroVive to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Organovo Holdings, Inc., a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3 D bioprinting technology, today announced that it has begun commercial contracting for its second tissue service, the ExVive TM Human Kidney. This kidney proximal tubule model is a natural expansion of the Company’ s preclinical product and service portfolio, allowing customers to study the effects of drug exposure on a..."/>
Organovo Announces Initiation of Commercial Contracting for ExVive Human Kidney Tissue
Biogen Inc., ImmunoGen Inc., Jazz Pharmaceuticals PLC, and Cempra Inc.."/>
Research Reports Coverage on Biotech Stocks -- Biogen, ImmunoGen, Jazz Pharma, and Cempra
InVivo Therapeutics Holdings Corp. today announced that Kristin Neff, Vice President of Clinical Operations& Project Management, is scheduled to present at the 55 th International Spinal Cord Society Annual Scientific Meeting to be held September 14-16, 2016 in Vienna, Austria. Neff was invited to present along with several other leaders in the field of spinal cord injury clinical research on September 14 during the symposium titled“ Clinical Trials..."/>
InVivo Therapeutics to Present at 55th International Spinal Cord Society Annual Scientific Meeting
Presbia PLC, an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens™, a propriety optical lens implant for treating the age-related loss of near-vision, announced that Jarett Fenton, CFO of Presbia, is scheduled to present at the Rodman& Renshaw 18 th Annual Healthcare Conference being held September 11 th through 13 th at the Lotte New York Palace Hotel in New York City. Fenton will be available for one-on-one..."/>
Presbia to Participate in the Rodman & Renshaw 18th Annual Healthcare Conference
Moleculin Biotech, Inc.,, today announced it will be featured as a presenting company at the 18 th Annual Rodman& Renshaw Global Investment Conference, sponsored by H.C. The conference is being held on September 11-13, 2016, at Lotte New York Palace Hotel in New York City. Walter Klemp, Chairman and Acting CEO, of Moleculin, will provide an overview of the Company's business during the live presentation and will be available to participate in..."/>
Moleculin Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016
AMAG Pharmaceuticals, Inc. announced today the appointment of Tony Casciano to senior vice president of sales and marketing for the company’ s Hematology and Oncology business. He will report to Nik Grund, AMAG’ s chief commercial officer.. “Tony Casciano has a proven track record of building profitable businesses and launching new products,” said Mr."/>
AMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing
Depomed, Inc. today announced that it will participate in a fireside chat at the 2016 Morgan Stanley Global Healthcare Conference scheduled for 2:15 pm ET on Monday, September 12, 2016 in New York, New York.. The fireside chat will be webcast live and may be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the event will be archived for 30 days on the company's website."/>
Depomed to Present at the Morgan Stanley Global Healthcare Conference
Calithera Biosciences, Inc., a clinical stage biotechnology company focused on the discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, today announced that clinical data for its lead drug candidate CB-839, the company's novel, orally bioavailable glutaminase inhibitor, will be presented at the 28th Annual EORTC-NCI-AACR Symposium on..."/>
Calithera Biosciences Announces CB-839 Clinical Data Selected for Oral Presentation at the 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Teva Pharmaceutical Industries Ltd. today announced that data on COPAXONE ®, a product for relapsing forms of multiple sclerosis, and laquinimod, an investigational therapy for relapsing and primary progressive forms of MS, will be presented at the 32 nd Congress of the European Committee for Treatment and Research in..."/>
Teva to Present Latest Data in Multiple Sclerosis at 2016 ECTRIMS Congress in London
Propanc Health Group Corporation, an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced it has submitted an application for Orphan Medicinal Product Designation to the European Medicines Agency for PRP, a solution for intravenous administration of pancreatic proenzymes trypsinogen and..."/>
Propanc Files Application for Orphan Medicinal Product Designation in the EU for Pancreatic Cancer
Syros Pharmaceuticals announced today that its management team will participate in the upcoming Morgan Stanley Global Healthcare Conference. Morgan Stanley Global Healthcare Conference Date: Wednesday, September 14 Location: Grand Hyatt New York, 109 East 42 nd Street, New York, NY. About Syros Pharmaceuticals Syros Pharmaceuticals is pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control..."/>
Syros Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
Pfizer Inc. announced today that Dr."/>
Pfizer Appoints Chief Scientific Officer for Neuroscience Research
Aurinia Pharmaceuticals Inc., today announced that its Chief Operating Officer, Michael R. Martin, will present a corporate overview of the Company at the 2016 Rodman& Renshaw 18th Annual Global Investment Conference, taking place September 11 th -13 th at the Lotte New York Palace Hotel in New York City. The presentation will also be available via webcast at the link listed below. About Aurinia Aurinia is a clinical stage biopharmaceutical company..."/>
Aurinia Pharmaceuticals to Present at the 2016 Rodman & Renshaw 18th Annual Global Investment Conference
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced..."/>
Catalyst Biosciences to Focus Resources on Clinical Hemostasis Programs
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming Rodman& Renshaw 18 th Annual Global Investment Conference, taking place September 11-13, 2016 in New York City. Nadav Kidron, Oramed's CEO, will present a corporate overview on September 12, 2016.."/>
Oramed to Present at the Rodman & Renshaw Global Investment Conference
Celsion Corporation today announced that Mr."/>
Celsion Corporation to Present at Upcoming Investor Conferences
Vericel Corporation, a leading developer of autologous expanded cellular therapies for the treatment of severe diseases and conditions, today announced the acceptance of an abstract for presentation at the American Heart Association’ s Scientific Sessions 2016 entitled“ Reduction in Ventricular Arrhythmias with Ixmyelocel-T: Results from the ixCELL? DCM Trial”. The poster will be presented by Timothy Henry, M.D., director of cardiology at..."/>
Vericel to Present Data at the American Heart Association’s Scientific Sessions 2016 on the Reduction of Ventricular Arrhythmias with Ixmyelocel-T in the ixCELL-DCM Clinical Trial
Spectral Medical Inc. a Phase III Company advancing a precision treatment targeting specific patients at high risk of death from endotoxemic septic shock, today announced it will be featured as a presenting company at the 18th Annual Rodman& Renshaw Global Investment Conference, sponsored by H.C. The conference is being held on September 11-13, 2016, at Lotte New York Palace Hotel in New York City. Paul Walker, President& CEO of Spectral Medical Inc.,..."/>
Spectral Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology679 Articles
Consumer Discretionary602 Articles
Financials390 Articles
Industrials375 Articles
Health Care353 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.